De Groot AS - Search Results

1

Species neutral correlates of immunogenicity for vaccines and protein therapeutics: fact or science fiction.

De Groot AS, Baker M, Cohen T. De Groot AS, et al. Hum Vaccin. 2010 May;6(5):371-2. Hum Vaccin. 2010. PMID: 20551718 Free PMC article. No abstract available.

2

Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori.

Moise L, McMurry JA, Pappo J, Lee DS, Moss SF, Martin WD, De Groot AS. Moise L, et al. Among authors: de groot as. Hum Vaccin. 2008 May-Jun;4(3):219-23. doi: 10.4161/hv.4.3.5394. Epub 2010 May 8. Hum Vaccin. 2008. PMID: 18376134

3

A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A.

McMurry JA, Johansson BE, De Groot AS. McMurry JA, et al. Among authors: de groot as. Hum Vaccin. 2008 Mar-Apr;4(2):148-57. doi: 10.4161/hv.4.2.5169. Epub 2007 Oct 14. Hum Vaccin. 2008. PMID: 18382131 Review.

4

Exploring the immunome: A brave new world for human vaccine development.

De Groot AS. De Groot AS. Hum Vaccin. 2009 Dec;5(12):790-3. doi: 10.4161/hv.10683. Epub 2009 Dec 15. Hum Vaccin. 2009. PMID: 20009527 Free PMC article. No abstract available.

5

Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.

De Groot AS, McClaine E, Moise L, Martin W. De Groot AS, et al. Hum Vaccin. 2010 Feb;6(2):161-63. doi: 10.4161/hv.6.2.11333. Epub 2010 Feb 19. Hum Vaccin. 2010. PMID: 20431339 Free PMC article. No abstract available.

6

A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM).

Cohen T, Moise L, Ardito M, Martin W, De Groot AS. Cohen T, et al. Among authors: de groot as. J Biomed Biotechnol. 2010;2010:961752. doi: 10.1155/2010/961752. Epub 2010 Jul 18. J Biomed Biotechnol. 2010. PMID: 20706613 Free PMC article.

7

Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes.

De Groot AS, Levitz L, Ardito MT, Skowron G, Mayer KH, Buus S, Boyle CM, Martin WD. De Groot AS, et al. Hum Vaccin Immunother. 2012 Jul;8(7):987-1000. doi: 10.4161/hv.20528. Epub 2012 Jul 1. Hum Vaccin Immunother. 2012. PMID: 22777092

8

Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease.

Cousens LP, Mingozzi F, van der Marel S, Su Y, Garman R, Ferreira V, Martin W, Scott DW, De Groot AS. Cousens LP, et al. Among authors: de groot as. Hum Vaccin Immunother. 2012 Oct;8(10):1459-64. doi: 10.4161/hv.21405. Epub 2012 Oct 1. Hum Vaccin Immunother. 2012. PMID: 23095864 Free PMC article.

9

The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix.

Moise L, Gutierrez AH, Bailey-Kellogg C, Terry F, Leng Q, Abdel Hady KM, VerBerkmoes NC, Sztein MB, Losikoff PT, Martin WD, Rothman AL, De Groot AS. Moise L, et al. Among authors: de groot as. Hum Vaccin Immunother. 2013 Jul;9(7):1577-86. doi: 10.4161/hv.24615. Epub 2013 Apr 12. Hum Vaccin Immunother. 2013. PMID: 23584251 Free PMC article.

10

Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.

De Groot AS, Ardito M, Terry F, Levitz L, Ross T, Moise L, Martin W. De Groot AS, et al. Hum Vaccin Immunother. 2013 May;9(5):950-6. doi: 10.4161/hv.24939. Epub 2013 May 1. Hum Vaccin Immunother. 2013. PMID: 23807079 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page